BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Clinical Outcome
14 results:

  • 1. The mutational landscape of a US Midwestern breast cancer cohort reveals subtype-specific cancer drivers and prognostic markers.
    Vellichirammal NN; Tan YD; Xiao P; Eudy J; Shats O; Kelly D; Desler M; Cowan K; Guda C
    Hum Genomics; 2023 Jul; 17(1):64. PubMed ID: 37454130
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genomic profile of metastatic breast cancer patient-derived xenografts established using percutaneous biopsy.
    Kim S; Shin D; Min A; Kim M; Na D; Lee HB; Ryu HS; Yang Y; Woo GU; Lee KH; Lee DW; Kim TY; Lee C; Im SA; Kim JI
    J Transl Med; 2021 Jan; 19(1):7. PubMed ID: 33407601
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Cathepsin V suppresses gata3 protein expression in luminal A breast cancer.
    Sereesongsaeng N; McDowell SH; Burrows JF; Scott CJ; Burden RE
    Breast Cancer Res; 2020 Dec; 22(1):139. PubMed ID: 33298139
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Racial Differences in the Association Between Luminal Master Regulator Gene Expression Levels and breast cancer Survival.
    Byun JS; Singhal SK; Park S; Yi DI; Yan T; Caban A; Jones A; Mukhopadhyay P; Gil SM; Hewitt SM; Newman L; Davis MB; Jenkins BD; Sepulveda JL; De Siervi A; Nápoles AM; Vohra NA; Gardner K
    Clin Cancer Res; 2020 Apr; 26(8):1905-1914. PubMed ID: 31911546
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004-2014).
    De Lara S; Nyqvist J; Werner Rönnerman E; Helou K; Kenne Sarenmalm E; Einbeigi Z; Karlsson P; Parris TZ; Kovács A
    BMC Cancer; 2019 Feb; 19(1):187. PubMed ID: 30819139
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Complex formation and function of estrogen receptor α in transcription requires RIP140.
    Rosell M; Nevedomskaya E; Stelloo S; Nautiyal J; Poliandri A; Steel JH; Wessels LF; Carroll JS; Parker MG; Zwart W
    Cancer Res; 2014 Oct; 74(19):5469-79. PubMed ID: 25145671
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. gata3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility.
    Theodorou V; Stark R; Menon S; Carroll JS
    Genome Res; 2013 Jan; 23(1):12-22. PubMed ID: 23172872
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. FoxM1 regulates mammary luminal cell fate.
    Carr JR; Kiefer MM; Park HJ; Li J; Wang Z; Fontanarosa J; DeWaal D; Kopanja D; Benevolenskaya EV; Guzman G; Raychaudhuri P
    Cell Rep; 2012 Jun; 1(6):715-29. PubMed ID: 22813746
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers.
    Shao R; Cao QJ; Arenas RB; Bigelow C; Bentley B; Yan W
    Br J Cancer; 2011 Oct; 105(8):1203-9. PubMed ID: 21934681
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. gata3 in development and cancer differentiation: cells GATA have it!
    Chou J; Provot S; Werb Z
    J Cell Physiol; 2010 Jan; 222(1):42-9. PubMed ID: 19798694
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. GATA-3 and the regulation of the mammary luminal cell fate.
    Kouros-Mehr H; Kim JW; Bechis SK; Werb Z
    Curr Opin Cell Biol; 2008 Apr; 20(2):164-70. PubMed ID: 18358709
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. High-dose-rate (hdr) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
    Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
    Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Identification of gata3 as a breast cancer prognostic marker by global gene expression meta-analysis.
    Mehra R; Varambally S; Ding L; Shen R; Sabel MS; Ghosh D; Chinnaiyan AM; Kleer CG
    Cancer Res; 2005 Dec; 65(24):11259-64. PubMed ID: 16357129
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Gene expression profiling of primary breast carcinomas using arrays of candidate genes.
    Bertucci F; Houlgatte R; Benziane A; Granjeaud S; Adélaïde J; Tagett R; Loriod B; Jacquemier J; Viens P; Jordan B; Birnbaum D; Nguyen C
    Hum Mol Genet; 2000 Dec; 9(20):2981-91. PubMed ID: 11115842
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.